Public Health

The link between reducing opioid prescriptions and mental health problems

During the opioid epidemic, reducing overdose fatalities has been the main priority for public health campaigners. However, a new study has explored the effects of reducing prescriptions. 

The study, which was carried out by researchers at the University of California, looked at the impact of health care providers reducing opioid prescriptions to treat patients in pain. 

One of the key findings of this study was that, despite practitioners aiming to lower the doses for patients using opioids for pain management, this may cause other issues.

They found that reducing the dosage for these patients could lead to more mental health problems and even an increase in overdoses. 

Researcher Alicia Agnoli said, “Prescribers are in a really difficult position. There are conflicting desires of ameliorating pain among patients while reducing the risk of adverse outcomes related to prescriptions.” 

“Our study showed an increased risk of overdose and mental health crisis following dose reduction. It suggests that patients undergoing tapering need significant support to safely reduce or discontinue their opioids.” 

How to help patients on opioids

For the study, the researchers analyzed the data of over 113,000 patients using opioids to manage their pain, including their hospital records. 

By comparing the records of those that had their doses reduced over a year to those that were kept on the same dosage, they found a link between lower doses and mental health problems. 

Reducing opioid prescriptions resulted in a 70% higher risk of a mental health emergency, with patients more likely to experience drug withdrawal, depression, anxiety, and suicidal thoughts. 

Alicia Agnoli added, “We hope that work will inform a more cautious and compassionate approach to decisions around opioid dose tapering.” 

“Our study may help shape clinical guidelines on patient selection for tapering, optimal rates of dose reduction, and how best to monitor and support patients during periods of dose transition.” 

Claire Robinson

Recent Posts

Nvidia Crisis Raises Questions About AI and National Security

  Nvidia has become one of the most influential companies in the artificial intelligence industry.…

2 days ago

How Hackers Stole $6.3 Billion From Binance

  A major cybersecurity incident at Binance has exposed the difficulties cryptocurrency exchanges face when…

1 week ago

Anthropic IPO Filing Reveals Serious AI Safety Risks

  Artificial intelligence company Anthropic has published an extensive list of potential risks as it…

2 weeks ago

Can Trump Lower Gas and Diesel Prices Before the Midterms?

  American drivers and businesses are facing higher energy expenses as the Trump administration attempts…

4 weeks ago

France Unrest Highlights Cost-of-Living and Service Crisis

  Growing frustration over household expenses and declining public services has fueled a wave of…

4 weeks ago

Skincubator for Premature Babies Makes Skin-to-Skin Care Easier

  For parents of premature babies, the first opportunity to hold their newborn can be…

1 month ago